Neurovascular Devices Market Size, Share, and Growth Analysis, By Disease Pathology (Cerebral Aneurysms, Ischemic Strokes), By End User (Hospitals And Surgical Centers, Ambulatory Care Centers), By Region - Industry Forecast 2025-2032
신경혈관 디바이스 시장 규모는 2023년에 37억 달러로 평가되며, 2024년 40억 1,000만 달러에서 2032년에는 77억 1,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 8.5%로 성장할 전망입니다.
세계 신경혈관 디바이스 시장은 신경질환 및 심혈관 질환의 유병률 증가에 힘입어 큰 성장을 보이고 있습니다. 인구 고령화와 신경혈관 질환에 대한 인식이 높아지면서 이러한 장비에 대한 수요가 더욱 증가하고 있습니다. 또한 최소침습 수술로의 전환, 의료기기 기술 발전, 조기 진단에 대한 관심은 시장 확대를 촉진할 것으로 예상됩니다. 급성 허혈성 뇌졸중의 높은 발생률은 전 세계 의료기기 제조업체들에게 새로운 기회를 제공합니다. 하지만, 높은 비용, 엄격한 규제 프레임워크, 신흥 시장에서의 접근성 제한, 잠재적인 합병증 등의 문제는 장기적인 시장 개발에 걸림돌이 될 수 있습니다. 전반적으로 이 시장은 유망한 성장 잠재력을 가진 시장이며, 그 전망을 극대화하기 위해서는 이러한 장애물을 극복해야 합니다.
목차
서론
조사 방법
- 정보 조달
- 2차와 1차 데이터 방법
- 시장 규모 예측
- 시장의 전제조건과 제한
개요
- 세계 시장 전망
- 공급과 수요 동향 분석
- 부문별 기회 분석
시장 역학과 전망
- 시장 개요
- 시장 규모
- 시장 역학
- Porter의 산업 분석
주요 시장 인사이트
- 주요 성공 요인
- 경쟁의 정도
- 주요 투자 기회
- 시장 에코시스템
- 시장의 매력 지수(2024년)
- PESTEL 분석
- 거시경제 지표
- 밸류체인 분석
- 가격 분석
- 특허 분석
- 사례 연구
- 고객과 구매 기준 분석
- 무역 분석
신경혈관 디바이스 시장 규모 : 질환 병리별 & CAGR(2025-2032)
- 시장 개요
- 뇌동맥류
- 색전코일
- 제외 가능한 베어 코일
- 코팅된 제외 가능한 코일
- 흐름 전환 기기
- 두개내 스텐트
- 마이크로카테터
- 가이드와이어
- 허혈성 뇌졸중
- 혈전 제거 기기
- 석션·흡인 기기
- 혈관 스네어
- 마이크로카테터
- 마이크로가이드와이어
- 풍선 카테터
- 경동맥협착증
- 동정맥 기형 및 누공
- 기타 질환 병리
신경혈관 디바이스 시장 규모 : 최종사용자별 & CAGR(2025-2032)
- 시장 개요
- 병원과 외과 센터
- 외래 진료 센터
- 조사실과 학술기관
신경혈관 디바이스 시장 규모 : 지역별 & CAGR(2025-2032)
- 북미
- 유럽
- 독일
- 스페인
- 프랑스
- 영국
- 이탈리아
- 기타 유럽 지역
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- GCC 국가
- 남아프리카공화국
- 기타 중동 및 아프리카
경쟁 정보
- 상위 5사의 비교
- 주요 기업의 시장 포지셔닝(2024년)
- 주요 시장 기업이 채택한 전략
- 최근 시장 동향
- 기업의 시장 점유율 분석(2024년)
- 주요 기업의 기업 개요
- 기업의 상세
- 제품 포트폴리오 분석
- 기업의 부문별 점유율 분석
- 매출의 전년대비 비교(2022-2024)
주요 기업 개요
- Acandis GmbH(Germany)
- Asahi Intecc Co. Ltd.(Japan)
- Imperative Care Inc.(United States)
- Integer Holdings Corporation(United States)
- Johnson & Johnson(United States)
- Medtronic plc(Ireland)
- MicroPort Scientific Corporation(China)
- Penumbra Inc.(United States)
- Perflow Medical Ltd.(Israel)
- Rapid Medical(Canada)
- Stryker Corporation(United States)
- Terumo Corporation(Japan)
- WL Gore & Associates(United States)
- Penumbra, Inc.(United States)(duplicate)
- Siemens Healthineers AG(Germany)
- Boston Scientific Corporation(United States)
- InspireMD, Inc.(Israel)
결론과 제안
KSA
Neurovascular Devices Market size was valued at USD 3.7 billion in 2023 and is poised to grow from USD 4.01 billion in 2024 to USD 7.71 billion by 2032, growing at a CAGR of 8.5% during the forecast period (2025-2032).
The global neurovascular devices market is witnessing significant growth driven by the rising incidence of neurological disorders and cardiovascular diseases. An aging population and increased awareness surrounding neurovascular disorders further propel demand for these devices. Additionally, the shift toward minimally invasive surgeries, technological advancements in medical devices, and a focus on early diagnosis are expected to enhance market expansion. High rates of acute ischemic stroke present new opportunities for device suppliers worldwide. However, challenges such as the high cost of neurovascular devices, stringent regulatory frameworks, limited access in developing regions, and potential complications may hinder long-term market development. Overall, while the market has promising growth potential, it must navigate these obstacles to maximize its outlook.
Top-down and bottom-up approaches were used to estimate and validate the size of the Neurovascular Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Neurovascular Devices Market Segments Analysis
Global Neurovascular Devices Market is segmented by Disease Pathology, End User and region. Based on Disease Pathology, the market is segmented into Cerebral Aneurysms, Ischemic Strokes, Carotid Artery Stenosis, Arteriovenous Malformation & Fistulas and Other Disease Pathologies. Based on End User, the market is segmented into Hospitals And Surgical Centers, Ambulatory Care Centers and Research Laboratories and Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Neurovascular Devices Market
The rising prevalence of neurovascular diseases, attributed to poor lifestyle choices and the widespread adoption of unhealthy habits, has led to a dramatic increase in the number of individuals affected by conditions like strokes and cerebral aneurysms globally. This growing incidence of neurovascular conditions is a significant driver fueling the demand for neurovascular devices. As more people seek medical interventions and solutions to address these escalating health issues, the market for neurovascular devices is expected to expand, providing opportunities for innovation and development in treatments aimed at managing and preventing such critical health challenges.
Restraints in the Neurovascular Devices Market
The Neurovascular Devices market faces a significant challenge due to the exorbitant costs associated with these advanced medical technologies. While developed countries may manage these expenses, healthcare institutions in developing nations often operate within constrained budgets, hindering their ability to procure such specialized devices. This financial barrier limits access to essential treatments and innovations in neurovascular care, potentially exacerbating healthcare disparities between different regions. As a result, the high costs of these devices may restrict their widespread adoption, ultimately impeding advancements in patient care and outcomes in less affluent healthcare systems.
Market Trends of the Neurovascular Devices Market
The Neurovascular Devices market is witnessing a significant shift towards the development of minimally invasive technologies, driven by a global preference for procedures that offer quicker recovery times and enhanced patient comfort. As healthcare professionals and patients increasingly seek alternatives to traditional surgical techniques, manufacturers are strategically investing in the innovation of neurovascular devices that facilitate less invasive interventions. This trend not only enhances treatment efficacy but also addresses the burgeoning demand for efficient healthcare solutions. Consequently, companies focusing on the advancement of minimally invasive neurovascular devices are likely to experience substantial sales growth and improve their competitive positioning in the market.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2024
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Patent Analysis
- Case Studies
- Customer And Buying Criteria Analysis
- Trade Analysis
Global Neurovascular Devices Market Size by Disease Pathology & CAGR (2025-2032)
- Market Overview
- Cerebral Aneurysms
- Embolic Coils
- Bare Detachable Coils
- Coated Detachable Coils
- Flow Diversion Devices
- Intracranial Stents
- Microcatheters
- Guidewires
- Ischemic Strokes
- Clot Retriever Devices
- Suction & Aspiration Devices
- Vascular Snares
- Microcatheters
- Microguidewires
- Balloon Catheters
- Carotid Artery Stenosis
- Carotid Artery Stents
- Embolic Protection Devices
- Balloon Catheters
- Arteriovenous Malformation & Fistulas
- Liquid Embolic Agents
- Occlusion Balloon Catheters
- Microcatheters
- Other Disease Pathologies
Global Neurovascular Devices Market Size by End User & CAGR (2025-2032)
- Market Overview
- Hospitals And Surgical Centers
- Ambulatory Care Centers
- Research Laboratories and Academic Institutes
Global Neurovascular Devices Market Size & CAGR (2025-2032)
- North America (Disease Pathology, End User)
- Europe (Disease Pathology, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Disease Pathology, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Disease Pathology, End User)
- Brazil
- Rest of Latin America
- Middle East & Africa (Disease Pathology, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2024
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2024
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
- Acandis GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Asahi Intecc Co. Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Imperative Care Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Integer Holdings Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Penumbra Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Perflow Medical Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Rapid Medical (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- WL Gore & Associates (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Penumbra, Inc. (United States) (duplicate)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- InspireMD, Inc. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
